Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07101263 · ClinicalTrials.gov registry record · NA
Whey Protein Comparisons for Blood Lipid Effects
A NA study of Cholesterol, sponsored by Medinutra.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT07101263 is a NA study of Cholesterol that is actively recruiting participants, run by Medinutra. The registered enrollment target is 72 participants, below the 763-participant average among 4 other Cholesterol trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07101263, a NA study of Cholesterol, is actively recruiting participants, sponsored by Medinutra.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are: * Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated? * Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation? Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol. Participants will: * Drink one protein beverage every day for 6 weeks; * Go to a LabCorp facility for a blood draw before and after the 6 weeks.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Standard whey
- DIETARY_SUPPLEMENT Hydrolyzed whey
Study Locations (1)
Ohio
- Medinutra LLC - Dublin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2026-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07101263
The ClinicalTrials.gov registry entry for NCT07101263 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 763-participant average among 4 other Cholesterol trials with a reported enrollment target (91% lower). The listed sponsor is Medinutra, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cholesterol appearing as the primary indexed condition, and to 2 interventions - of which Standard whey is the first listed.
NCT07101263 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07101263 about?
NCT07101263 is a clinical study titled "Whey Protein Comparisons for Blood Lipid Effects". The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are: * Will hydrolyzed whe...
What is the current status of trial NCT07101263?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2025-08-05. Estimated completion is 2026-01-15.
What conditions does trial NCT07101263 study?
This clinical trial studies the following conditions: Cholesterol.
What interventions are being tested in trial NCT07101263?
The interventions under investigation include: Standard whey (DIETARY_SUPPLEMENT), Hydrolyzed whey (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07101263?
This trial is sponsored by Medinutra, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07101263 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cholesterol
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Mental and Physical Health of Women Veterans
ACTIVE NOT RECRUITING · NA
-
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
RECRUITING · Early Phase 1
-
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
RECRUITING · Early Phase 1
-
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.